Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy. (Q40372701)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 2005
edit
Language Label Description Also known as
English
Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy.
scientific article published on September 2005

    Statements

    title
    Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    16166447
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16166447%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    6 January 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q40372701&oldid=1493910738"